» Articles » PMID: 32917442

Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Primer for Emergency Physicians

Overview
Journal J Emerg Med
Publisher Elsevier
Specialty Emergency Medicine
Date 2020 Sep 12
PMID 32917442
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) impose a significant burden on patients and the emergency health care system. Patients with COPD who present to the emergency department (ED) often have comorbidities that can complicate their management.

Objective: To discuss strategies for the management of acute exacerbations in the ED, from initial assessment through disposition, to enable effective patient care and minimize the risk of treatment failure and prevent hospital readmissions.

Discussion: Establishing a correct diagnosis early on is critical; therefore, initial evaluations should be aimed at differentiating COPD exacerbations from other life-threatening conditions. Disposition decisions are based on the intensity of symptoms, presence of comorbidities, severity of the disease, and response to therapy. Patients who are appropriate for discharge from the ED should be prescribed evidence-based treatments and smoking cessation to prevent disease progression. A patient-centric discharge care plan should include medication reconciliation; bedside "teach-back," wherein patients demonstrate proper inhaler usage; and prompt follow-up.

Conclusions: An effective assessment, accurate diagnosis, and appropriate discharge plan for patients with AECOPD could improve treatment outcomes, reduce hospitalization, and decrease unplanned repeat visits to the ED.

Citing Articles

Clinical and Economic Evaluation of Fluticasone Furoate/Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol Therapy in Maintenance Treatment-Naive Patients with COPD in the US.

Shaikh A, Ritz J, Casciano J, Palli S, Clark B, Dotiwala Z Int J Chron Obstruct Pulmon Dis. 2025; 20:335-348.

PMID: 39968202 PMC: 11834697. DOI: 10.2147/COPD.S479504.


Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease.

Mannino D, Weng S, Germain G, Boudreau J, Tardif-Samson A, Forero-Schwanhaeuser S Adv Ther. 2024; 42(2):1131-1146.

PMID: 39731707 PMC: 11787206. DOI: 10.1007/s12325-024-03088-1.


Association between antibiotics and rehospitalization in patients with acute exacerbations of chronic obstructive pulmonary disease discharged from the emergency department.

Zheng B, Taljaard M, Aaron S, Yadav K, Rowe B, Chan C CJEM. 2022; 24(7):725-734.

PMID: 36242731 DOI: 10.1007/s43678-022-00373-2.


Statins Associated with Better Long-Term Outcomes in Aged Hospitalized Patients with COPD: A Real-World Experience from Pay-for-Performance Program.

Chen Y, Li T, Li C, Lin S, Fu P J Pers Med. 2022; 12(2).

PMID: 35207787 PMC: 8877141. DOI: 10.3390/jpm12020299.


Procalcitonin kinetics to guide sequential invasive-noninvasive mechanical ventilation weaning in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: procalcitonin's adjunct role.

Lin S, He Y, Lian J, Chu C Libyan J Med. 2021; 16(1):1961382.

PMID: 34357857 PMC: 8354150. DOI: 10.1080/19932820.2021.1961382.